Xeno Trade Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 28.24%
- Profit Growth -13318.66%
- Ebitda -4.23%
- Net Worth -465.18%
- Total Assets -47.42%
About Xeno Trade
Xeno Trade Private Limited (XTPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 May 2009 and has a history of 15 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Consumer Electronics & Durables Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Unjin No, Myung Chun, and Vivek Shukla serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909DL2009PTC190334
- Company No.
190334
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Consumer Electronics & Durables
What products or services does Xeno Trade Private Limited offer?
Xeno Trade Private Limited offers a wide range of products and services, including Laboratory Chemicals, Tea & Coffee, Coffee, Air Compressors, Accessories & Parts, Compressor Spares, Air Compressors, Automobile Compressor.
Who are the key members and board of directors at Xeno Trade?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Unjin No  | Director | 15-May-2009 | Current |
| Myung Chun | Director | 27-Jul-2009 | Current |
Vivek Shukla  | Director | 14-Oct-2022 | Current |
Financial Performance of Xeno Trade.
Xeno Trade Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 28.24% increase. The company also saw a substantial fall in profitability, with a 13318.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 465.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xeno Trade?
In 2017, Xeno Trade had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xeno Trade?
Unlock and access historical data on people associated with Xeno Trade, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xeno Trade, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xeno Trade's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
